1 Seven benzodiazepines were investigated for their ability to interact with receptors for thyrotropin-releasing hormone (TRH) on GH3 and GH4C1 pituitary tumour cells. 2 Midazolam and chlordiazepoxide were the most potent inhibitors of TRH-induced [3H]-inositol phosphate formation with Ki values in the low micromolar range. The antagonism was competitive in nature and was increased in potency at sub-physiological temperatures. 3 None of the agents examined antagonized bombesin-induced [3H]-inositol phosphate formation in GH4C1 cells.
Introduction
The elucidation of the physiological role of thyrotropin-releasing hormone (TRH) has been significantly hindered by the absence of a specific antagonist. Binding of TRH to its receptor in the CNS has recently been demonstrated to be inhibited by a number of benzodiazepines, in particular, chlordiazepoxide (Sharif et al., 1983; Simasko & Horita, 1984) . A similar conclusion has been reached from work on the TRH receptor of pituitary cells (Sharif et al., 1983; Gershengorn & Paul, 1986 ) and, in the GH3 cell line, additional studies indicate that the benzodiazepine-TRH receptor interaction is of an antagonist nature (Drummond, 1985; Gershengorn & Paul, 1986; Martin et al., 1986) . However, chlordiazepoxide fails to satisfy the requirement for a specific TRH antagonist because of its powerful interaction with the GABA system. Nevertheless, the finding raises the possibility that other benzodiazepines or related substances might retain TRH recep- ' Author for correspondence at present address: Department of Pharmacology, British Bio-technology Ltd., Brook House, Wallington Road, Cowley, Oxford OX4 SLY. tor blocking activity while being devoid of a GABAergic action.
The cellular effects of TRH are now recognised to be the result of stimulated inositol lipid hydrolysis, a process which has been widely characterized in clonal pituitary cells (for recent reviews, see Drummond, 1986; Gershengorn, 1986) . In an attempt to characterize further the molecular requirements for the benzodiazepine-TRH receptor interaction, we have investigated the ability of a number of related benzodiazepines to act as inhibitors of TRHstimulated inositol phosphate formation in two pituitary cell lines. Of the substances tested, only the anaesthetic agent, midazolam, exceeds chlordiazepoxide in activity. 1984) in 100mm petri-dishes (Nunc, Gibco, Paisley, Scotland); 7-10 days after plating, [3H]-inositol (7pCi per dish; 9 ml) was added and the cells allowed to grow for a further 2-3 days. Previous work has shown that, under those conditions, labelling of the inositol lipids in GH3 cells has reached isotopic equilibrium . On the day of the experiment, cell suspensions were prepared in a balanced salt solution containing (mM): lithium chloride 10, sodium chloride 125, potassium chloride 4.5, calcium chloride 1.5, magnesium chloride 0.5, glucose 5.6, HEPES 10, sodium pyruvate 1, disodium hydrogen phosphate 1.86, 0.1% (w/v) BSA pH 7.4 with sodium hydroxide.
Cell stimulation and isolation of [3H]-inositol phosphates Aliquots (0.5 ml) of cell suspension (containing around 250.ug cell protein) were incubated at 370C (unless otherwise stated) with various concentrations of TRH, bombesin and the benzodiazepines for the times indicated in the table or figure legends. The presence of lithium ions (10mM) has been shown to amplify considerably agonist-induced inositol phosphate formation in a wide range of cells and tissues including GH3 cells (Berridge et al., 1982; . The reactions were stopped by addition of an equal volume of 20% (w/v) TCA. After 15min on ice, precipitated proteins were removed by centrifugation and the remaining TCA extracted by three washes with 3.5 ml of watersaturated ether.
[3H]-inositol and its mono-, bis-, tris-, and tetrakisphosphates in the neutralised cell extract were separated by sequential elution from Biorad AG 1-X8 (200-400 mesh, formate form) anion-exchange resin as described by Downes et al. (1986) . 
Results
The effect of benzodiazepines on TRH-induced inositol phosphateformation in lithium treated GH3 cells The structures of the benzodiazepines investigated in this study are outlined in Figure 1 . Incubation of lithium-treated GH3 cells with TRH (10-9M) for 15 min leads to the accumulation of a variety of inositol phosphates . The data in Table 1 show the effect of a number of agents (at 10-'M) on [3H]-inositol monophosphate levels in Figure I Structures of the benzodiazepines studied for their abilities to interact with TRH at its receptor in GH pituitary cells. * denotes the position of the assymmetric carbon atom for the enantiomers of 4methyl midazolam.
TRH-stimulated cells. None of the agents examined significantly altered basal [3H]-InsP levels with the exception of (±)-4-hydroxymidazolam which caused a small increase of around 20% in this and two other experiments. All, however, except adinazolam caused an attenuation of the TRH-induced response, with midazolam and chlordiazepoxide being the most potent. The nature of the antagonism of TRH action by midazolam was further investigated by compiling concentration-response curves for TRH in the presence and absence of midazolam (5 x 10 5M) ( Figure 2 ). In the presence of midazolam, the ability of TRH to increase the cellular content of the various inositol phosphates was shifted by around 25 fold to the right in a parallel manner, indicating [TRHJ (M) Figure 2 Antagonism of TRH-induced inositol phosphate accumulation in lithium-treated GH3 cells by midazolam (5 x 10-5M). Cells, prelabelled with [3H]inositol (7pCi per dish for 48h), were incubated with various concentrations of TRH in the presence (0) or absence (0) of midazolam (5 x 10-5M (Drummond, 1985) was 1.4 x 10-I M, indicating that the imidazobenzodiazepine was the more potent receptor antagonist.
Interestingly, when the incubation temperature was reduced to 250C, midazolam and chlordiazepoxide were more potent antagonists. At the lower temperature, the Ki for midazolam, for example, against the TRH-induced responses was 7 x 10-7M (data not shown). A similar increase in antagonist potency has recently been observed at 250C in [3H]-TRH (±)4-Hydroxy-midazolam, a metabolite of midazolam, was a less potent inhibitor of TRH-induced inositol phosphate formation, when analysed using a similar experimental design, having a mean Ki of 3 x 10-5tM (data not shown). One notable feature of these experiments, which confirms and extends previous work (Drummond, 1985) , was the finding that while the Ki for a particular benzodiazepine against the TRH-induced accumulation of the different inositol phosphates was very similar, the potency of TRH in stimulating their accumulation was not. In particular, the EC50 for TRH-induced InsP, and InsP4 formation (1 + 0.3 x 10-9M; four experiments) was significantly less than that for the accumulation of InsP3 (6 + 0.2 x 1O-M). The implication may be that the Ins(1,4,5)P3 kinase may saturate with substrate during stimulation with high concentrations of the tripeptide.
The availability of two stereoisomers of 4methylmidazolam allowed us to investigate whether the TRH receptor, like the GABAA receptorionophore complex (Mohler & Okada, 1977) , exhibited a steric preference for benzodiazepines. The data presented in Figure 3 indicate that both (+) and (-)-4-methylmidazolam were active as TRH antagonists, although in three experiments of this type, the ( +)isomer was about twice as active.
Specificity ofbenzodiazepinesfor the TRH receptor
The bombesin receptor on GH3 cells is also coupled to changes in inositol lipid metabolism (Sutton & Martin, 1982) . Most GH3 cell clones, however, have only a small number of such receptors and the magnitude of the bombesin-induced rise in inositol phosphates is difficult to measure (Drummond, 1985) . For this reason, the demonstration that benzodiazepines do not act at some post-receptor stage in the cellular signalling process required the use of a related pituitary cell clone, the GH4C1 line, which is much more responsive to bombesin. Table 2 obtained from incubating lithium-treated GH4C, cells with a low concentration of TRH or bombesin in the presence or absence of various benzodiazepines at a fixed concentration. With all three drugs, only the TRH response was inhibited. In order to confirm that this lack of effect of the benzodiazepines on the bombesin response was not due to the inappropriate selection of a receptor-saturating bombesin concentration, full concentration-response curves for bombesin-induced InsP formation in GH4C1 cells were constructed in the absence or presence of a fixed benzodiazepine concentration. This work, presented in Figure 4 for midazolam, shows that the drug was without effect at any bombesin concentration, despite its evident ability to inhibit TRH in the same experiment. Similar results were obtained for chlordiazepoxide and (± )-4-hydroxymidazolam (both at2 x 10-4M).
Chlordiazepoxide as a pharmacological tool
Characteristically, TRH-induced changes in inositol phosphates in GH3 cells are long-lived. This steadystate level, however, gives no information as to the rate at which these substances are produced and metabolised following prolonged receptor stimulation. As is demonstrated in Figure 5 , the elevated levels of InsP3 and InsP2 in GH3 cells stimulated by TRH represent a dynamic equilibrium, addition of the TRH receptor antagonist, chlordiazepoxide (2 x 10-3M), at times up to 60min after initiation of the reaction, leads to an immediate decline in the cellular content of these metabolites. Similar data were found in studies using lower concentrations of chlordiazepoxide (2 x 10-4M) in which the same ratio of [agonist] to [antagonist] was maintained (data not shown). These data contradict the report of Imai & Gershengorn (1986) which suggested that InsP3 production was a transient phenomenon. The data in 'or Figure 5 also demonstrate that the cellular content of InsP falls rather slowly following displacement of TRH from its receptor. This is probably due to the ability of lithium to inhibit the metabolism of InsP more markedly than that of its phosphorylated derivatives.
Discussion
This work was conducted with the general aim of developing further the pharmacology of the benzodiazepine-TRH receptor interaction. It has demonstrated that a number of 1,2-annelated benzodiazepines show varying degrees of ability to interact with the TRH receptor as competitive antagonists. The anaesthetic agent, midazolam, in particular, is the most potent TRH receptor blocker so far identified, thus confirming the TRH receptor binding data of Rinehart et al. (1986) . Although around 20 structurally related substances have now been examined in CNS binding assays and in studies of TRHinduced cellular effects, there is still no substantial breakthrough in identifying a benzodiazepine which has potent TRH receptor blocking action in the absence of GABA-potentiating effects. What is now abundantly clear, however, is that the benzodiazepine pharmacology at the TRH receptor and at the GABAA receptor-ionophore is markedly different.
For example, while GABA-related effects are clearly dependent on the stereochemistry at the 3-position (this is analogous to the 4-position in the imidazobenzodiazepine series) such that (+)isomers of 3-substituted benzodiazepines are >100 fold more potent than their corresponding (-)-isomers (Mohler & Okada, 1977) , this is not the case for the TRH receptor, as seen with the isomers of 4methylmidazolam. A number of structurally advantageous and deleterious substitutions on the basic benzodiazepine nucleus are now, however, evident. In general, drugs substituted in the 1 and 2 positions are more potent TRH antagonists than their unsubstituted counterparts: demoxepam is much less potent than chlordiazepoxide or diazepam (Drummond, 1985) and certain 1,2-annelated compounds e.g. midazolam, are even more active than chlordiazepoxide.
There is a rather marked discrepancy between the potency of a number of benzodiazepines as TRH antagonists measured in the rat brain TRH receptor binding assay and in studies of cellular responses in GH3 cells. For example, Rinehart et al. (1986) using rat amygdala membranes, found IC50 values for midazolam and chlordiazepoxide of 0.63 and 3.68 x 10-7M respectively. This contrasts with Ki values measured in GH3 cells of 3.2 and 15 x 10-6M for midazolam and chlordiazepoxide respectively.
One piece of information to emerge from the present study is that the affinity of the benzodiazepine for the TRH receptor is markedly dependent on the reaction temperature: midazolam was 4-5 times more potent as a TRH antagonist at 25°C than at 37°C. Although the reasons for this remain unknown, it seems that the low temperature (40C) used in the CNS binding assays may have overestimated receptor affinity for physiological conditions. In support of this, it is noteworthy that Gershengorn & Paul (1986) report a Ki for chlordiazepoxide-TRH receptor binding in GH cells of 5 x 10-6M at 37°C; this is significantly higher (10-20 fold) than that found in CNS binding studies conducted at 4°C.
As previously argued for chlordiazepoxide (Drummond, 1985) , it seems unlikely that the interaction of midazolam with the TRH receptor will have significant therapeutic ramifications. The blood concentration of this drug achieved after administration of an anaesthetic dose to an adult will be in the range 1-4 x 10-7M (Puglisi et al., 1978) . This is below a midazolam concentration that would compete effectively with TRH for binding to its receptor. Moreover, although we were unable to test its major human metabolite, a-hydroxymidazolam, for TRH receptor blocking activity, another metabolite, 4-hydroxymidazolam, was much weaker than the parent molecule.
The use of chlordiazepoxide has been informative in probing the mechanisms underlying the formation and metabolism of inositol phosphates following TRH receptor stimulation in GH3 cells. Measurements of changes in the specific activity of the inositol phospholipids in 32P-labelled GH3 cells stimulated by TRH led Imai & Gershengorn (1986) to propose that PtdIns(4,5)P2 hydrolysis is transient. The data presented here contradict this view for the following reasons. Firstly, we and others (Schlegel et al., 1984; Drummond & Raeburn, 1984) have shown that increases in InsP3 and InsP2 are long-lived following TRH stimulation of GH3 cells. Secondly, antagonism of the TRH-induced inositol phosphate response by adding chlordiazepoxide once an elevated steady-state level has been established, leads to an immediate fall in the levels of InsP2 and InsP3. Thirdly, formation of Ins4P, a product of polyphosphoinositide but not PtdIns metabolism, continues for a considerable length of time (> 20min) in TRH-stimulated GH3 cells (Dean & Moyer, 1987; Hughes & Drummond, 1987) . Taken together, these data indicate that the elevated level of the inositol polyphosphates is maintained by continued rather than transient biosynthesis.
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